
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $2.1M | $11.1M | $22M | $43.1M | |
Revenue Growth (YoY) | -- | -- | 430.3% | 98.02% | 95.41% | |
Cost of Revenues | $143K | $1M | $2.9M | $8.1M | $20.6M | |
Gross Profit | -$143K | $1.1M | $8.2M | $13.9M | $22.5M | |
Gross Profit Margin | -- | 50.45% | 73.55% | 63.22% | 52.18% | |
R&D Expenses | $10.2M | $20.2M | $44M | $92.3M | $136.8M | |
Selling, General & Admin | $4M | $17M | $44.4M | $69M | $99.5M | |
Other Inc / (Exp) | $309K | -$67.6M | $30.1M | -$19.3M | -$117.4M | |
Operating Expenses | $15.6M | $39.7M | $93.9M | $171.7M | $254.9M | |
Operating Income | -$15.7M | -$38.7M | -$85.7M | -$157.8M | -$232.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$15.4M | -$106.2M | -$48.5M | -$157.7M | -$331.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $48K | $59K | |
Net Income to Company | -$15.4M | -$106.2M | -$48.5M | -$157.8M | -$331.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$15.4M | -$106.2M | -$48.5M | -$157.8M | -$331.6M | |
Basic EPS (Cont. Ops) | -$0.08 | -$0.77 | -$0.25 | -$0.78 | -$1.56 | |
Diluted EPS (Cont. Ops) | -$0.08 | -$0.77 | -$0.25 | -$0.78 | -$1.56 | |
Weighted Average Basic Share | $192.5M | $137.6M | $197.7M | $202.6M | $213M | |
Weighted Average Diluted Share | $192.5M | $137.6M | $197.7M | $202.6M | $213M | |
EBITDA | -$14.3M | -$36.1M | -$80.1M | -$147.4M | -$213.8M | |
EBIT | -$15.7M | -$38.7M | -$85.7M | -$157.8M | -$232.5M | |
Revenue (Reported) | -- | $2.1M | $11.1M | $22M | $43.1M | |
Operating Income (Reported) | -$15.7M | -$38.7M | -$85.7M | -$157.8M | -$232.5M | |
Operating Income (Adjusted) | -$15.7M | -$38.7M | -$85.7M | -$157.8M | -$232.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $125K | $2M | $4.3M | $7.6M | $7.6M | |
Revenue Growth (YoY) | -- | 1462.4% | 119.41% | 76.94% | -0.21% | |
Cost of Revenues | $181K | $568K | $1M | $3.4M | $4.3M | |
Gross Profit | -$56K | $1.4M | $3.2M | $4.2M | $3.3M | |
Gross Profit Margin | -44.8% | 70.92% | 75.82% | 54.97% | 42.97% | |
R&D Expenses | $3.7M | $7.3M | $16.2M | $32.4M | $40M | |
Selling, General & Admin | $3.2M | $11.1M | $13.2M | $20.7M | $32.4M | |
Other Inc / (Exp) | $3K | $13.4M | -$3.5M | $8.5M | $38.5M | |
Operating Expenses | $7.3M | $19.7M | $31.3M | $57M | $78.9M | |
Operating Income | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $8K | $12K | |
Net Income to Company | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Basic EPS (Cont. Ops) | -$0.04 | -$0.02 | -$0.14 | -$0.19 | -$0.14 | |
Diluted EPS (Cont. Ops) | -$0.04 | -$0.02 | -$0.14 | -$0.19 | -$0.14 | |
Weighted Average Basic Share | $192.5M | $196.2M | $200.1M | $208.2M | $228.8M | |
Weighted Average Diluted Share | $192.5M | $196.2M | $200.1M | $208.2M | $228.8M | |
EBITDA | -$6.9M | -$17M | -$26.2M | -$48.9M | -$69.1M | |
EBIT | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Revenue (Reported) | $125K | $2M | $4.3M | $7.6M | $7.6M | |
Operating Income (Reported) | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Operating Income (Adjusted) | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $3.9M | $13.5M | $25.3M | $43.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $1.4M | $3.4M | $10.5M | $21.5M | |
Gross Profit | -- | $2.5M | $10.1M | $14.9M | $21.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $23.9M | $52.9M | $108.5M | $144.4M | |
Selling, General & Admin | -- | $24.9M | $46.5M | $76.5M | $111.1M | |
Other Inc / (Exp) | $18K | -$54.1M | $13.1M | -$7.3M | -$87.3M | |
Operating Expenses | -- | $52.1M | $105.5M | $197.5M | $276.8M | |
Operating Income | -- | -$49.6M | -$95.5M | -$182.6M | -$255.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$103.1M | -$71.6M | -$170M | -$324.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $56K | $63K | |
Net Income to Company | -- | -$103.1M | -$71.6M | -$170M | -$324.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$103.1M | -$71.6M | -$170M | -$324.3M | |
Basic EPS (Cont. Ops) | -- | -$0.54 | -$0.36 | -$0.84 | -$1.51 | |
Diluted EPS (Cont. Ops) | -- | -$0.54 | -$0.36 | -$0.84 | -$1.51 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$46.3M | -$89.4M | -$170.1M | -$234M | |
EBIT | -- | -$49.6M | -$95.5M | -$182.6M | -$255.3M | |
Revenue (Reported) | -- | $3.9M | $13.5M | $25.3M | $43.1M | |
Operating Income (Reported) | -- | -$49.6M | -$95.5M | -$182.6M | -$255.3M | |
Operating Income (Adjusted) | -- | -$49.6M | -$95.5M | -$182.6M | -$255.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $125K | $2M | $4.3M | $7.6M | $7.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $181K | $568K | $1M | $3.4M | $4.3M | |
Gross Profit | -$56K | $1.4M | $3.2M | $4.2M | $3.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.7M | $7.3M | $16.2M | $32.4M | $40M | |
Selling, General & Admin | $3.2M | $11.1M | $13.2M | $20.7M | $32.4M | |
Other Inc / (Exp) | $3K | $13.4M | -$3.5M | $8.5M | $38.5M | |
Operating Expenses | $7.3M | $19.7M | $31.3M | $57M | $78.9M | |
Operating Income | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $8K | $12K | |
Net Income to Company | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Basic EPS (Cont. Ops) | -$0.04 | -$0.02 | -$0.14 | -$0.19 | -$0.14 | |
Diluted EPS (Cont. Ops) | -$0.04 | -$0.02 | -$0.14 | -$0.19 | -$0.14 | |
Weighted Average Basic Share | $192.5M | $196.2M | $200.1M | $208.2M | $228.8M | |
Weighted Average Diluted Share | $192.5M | $196.2M | $200.1M | $208.2M | $228.8M | |
EBITDA | -$6.9M | -$17M | -$26.2M | -$48.9M | -$69.1M | |
EBIT | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Revenue (Reported) | $125K | $2M | $4.3M | $7.6M | $7.6M | |
Operating Income (Reported) | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M | |
Operating Income (Adjusted) | -$7.3M | -$18.3M | -$28M | -$52.9M | -$75.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $36.1M | $399M | $44.4M | $35.7M | $54.4M | |
Short Term Investments | -- | $123.4M | $311.4M | $319.8M | $285.9M | |
Accounts Receivable, Net | $390K | $261K | $1.2M | $8.6M | $6.5M | |
Inventory | -- | -- | $5.2M | $12.5M | $18.7M | |
Prepaid Expenses | -- | -- | $4M | $5.7M | $4.9M | |
Other Current Assets | $2.1M | $6.4M | $3.4M | $2.8M | $2.6M | |
Total Current Assets | $38.6M | $529.6M | $371.6M | $390M | $378.8M | |
Property Plant And Equipment | $16.3M | $22.9M | $29.8M | $42.1M | $62.2M | |
Long-Term Investments | -- | $80.1M | $182M | $100.5M | $23.5M | |
Goodwill | -- | -- | $742K | $742K | $9.9M | |
Other Intangibles | $2.7M | $5.8M | $8.9M | $15.1M | $29.5M | |
Other Long-Term Assets | $2.9M | $3.6M | $4.9M | $5.2M | $4.4M | |
Total Assets | $60.5M | $642M | $598M | $553.6M | $508.4M | |
Accounts Payable | $538K | $1.9M | $3.1M | $5.6M | $5.2M | |
Accrued Expenses | $608K | $2.6M | $6.7M | $18.4M | $16.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $495K | $568K | $591K | $710K | $3.4M | |
Other Current Liabilities | -- | $1.2M | $1.1M | $392K | $387K | |
Total Current Liabilities | $1.9M | $9.7M | $20.2M | $37.2M | $36.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.8M | $50.8M | $29.8M | $68.6M | $124.5M | |
Common Stock | $3K | $19K | $20K | $20K | $22K | |
Other Common Equity Adj | -- | -$148K | -$7.4M | -$2M | $157K | |
Common Equity | $53.7M | $591.2M | $568.2M | $485M | $383.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $53.7M | $591.2M | $568.2M | $485M | $383.9M | |
Total Liabilities and Equity | $60.5M | $642M | $598M | $553.6M | $508.4M | |
Cash and Short Terms | $36.1M | $522.5M | $355.8M | $355.4M | $340.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $86.8M | $51.9M | $60.1M | $159.7M | |
Short Term Investments | -- | $329.2M | $336M | $206.1M | $428.6M | |
Accounts Receivable, Net | -- | $97K | $1M | $8.6M | $6.9M | |
Inventory | -- | -- | -- | $16.2M | $24M | |
Prepaid Expenses | -- | -- | -- | $5.1M | $4.5M | |
Other Current Assets | -- | $5.8M | $12.6M | $3.6M | $6.7M | |
Total Current Assets | -- | $422.3M | $402.3M | $409.9M | $637M | |
Property Plant And Equipment | -- | $25.1M | $32.3M | $51.6M | $60.9M | |
Long-Term Investments | -- | $170.5M | $137.6M | $45.5M | $108.9M | |
Goodwill | -- | -- | $742K | $726K | $10.7M | |
Other Intangibles | -- | -- | $10.1M | $16.9M | $28.2M | |
Other Long-Term Assets | -- | $3.4M | $4.9M | $5.6M | $4.5M | |
Total Assets | -- | $627.5M | $587.9M | $543.9M | $850.1M | |
Accounts Payable | -- | $2M | $3.6M | $5.9M | $8.8M | |
Accrued Expenses | -- | $4.3M | $9.4M | $10.5M | $23.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $573K | $610K | $1.2M | $3.6M | |
Other Current Liabilities | -- | $1.1M | $945K | $392K | $350K | |
Total Current Liabilities | -- | $11.4M | $20.9M | $34.7M | $48.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $37.7M | $35.7M | $64.1M | $85M | |
Common Stock | -- | $20K | $20K | $21K | $24K | |
Other Common Equity Adj | -- | -$4.7M | -$5.4M | -$1.7M | -$11K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $589.8M | $552.2M | $479.8M | $765M | |
Total Liabilities and Equity | -- | $627.5M | $587.9M | $543.9M | $850.1M | |
Cash and Short Terms | -- | $415.9M | $387.9M | $266.2M | $588.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$15.4M | -$106.2M | -$48.5M | -$157.8M | -$331.6M | |
Depreciation & Amoritzation | $1.4M | $2.5M | $5.6M | $10.4M | $18.7M | |
Stock-Based Compensation | $1.2M | $7.7M | $31.5M | $69.7M | $106.9M | |
Change in Accounts Receivable | -$290K | -$317K | -$1.5M | -$8.2M | $1.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$12M | -$26.5M | -$44.7M | -$78.8M | -$105.7M | |
Capital Expenditures | -- | $10M | $12.6M | $19.5M | $23.6M | |
Cash Acquisitions | -- | -- | -$848K | -- | -$15.5M | |
Cash From Investing | -$11.7M | -$213.8M | -$309.1M | $68.8M | $82.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $572.7M | $20K | -$230K | $238K | |
Cash From Financing | $276K | $603.2M | $1.1M | $1.8M | $41.7M | |
Beginning Cash (CF) | $59.5M | $36.1M | $399M | $46.4M | $38.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$23.4M | $362.9M | -$352.7M | -$8.3M | $18.7M | |
Ending Cash (CF) | $36.1M | $399M | $46.4M | $38.1M | $56.8M | |
Levered Free Cash Flow | -$23.7M | -$36.6M | -$57.3M | -$98.4M | -$129.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Depreciation & Amoritzation | $445K | $1.3M | $1.8M | $4M | $6.6M | |
Stock-Based Compensation | $1.4M | $6.7M | $10.3M | $22.1M | $33.3M | |
Change in Accounts Receivable | $318K | $138K | $2M | $1.9M | $748K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.9M | -$8.3M | -$13.8M | -$20.5M | -$33M | |
Capital Expenditures | $2.2M | $3.3M | $2.3M | $4.9M | $3.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.2M | -$304.1M | $21.3M | $43.5M | -$230.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $16K | -$18K | $873K | $516K | |
Cash From Financing | $5.4M | $148K | $34K | $1.4M | $368.7M | |
Beginning Cash (CF) | $36.1M | $399M | $46.4M | $38.1M | $56.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $4K | -$13K | |
Additions / Reductions | -$689K | -$312.3M | $7.5M | $24.4M | $105.5M | |
Ending Cash (CF) | $35.4M | $86.8M | $53.9M | $62.5M | $162.4M | |
Levered Free Cash Flow | -$6.1M | -$11.6M | -$16.2M | -$25.4M | -$36.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$103.1M | -$71.6M | -$170M | -$324.3M | |
Depreciation & Amoritzation | -- | $3.4M | $6.1M | $12.5M | $21.3M | |
Stock-Based Compensation | $1.4M | $13M | $35.1M | $81.5M | $118.1M | |
Change in Accounts Receivable | -- | -$497K | $396K | -$8.3M | $460K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$31M | -$50.2M | -$85.5M | -$118.2M | |
Capital Expenditures | $2.2M | $11.1M | $11.6M | $22.1M | $22.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$515.7M | $16.4M | $91M | -$191M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$14K | $661K | -$119K | |
Cash From Financing | -- | $598M | $982K | $3.1M | $409.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $51.3M | -$32.9M | $8.6M | $99.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$42.1M | -$61.8M | -$107.6M | -$140.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.3M | -$4.2M | -$27.3M | -$39.6M | -$32.3M | |
Depreciation & Amoritzation | $445K | $1.3M | $1.8M | $4M | $6.6M | |
Stock-Based Compensation | $1.4M | $6.7M | $10.3M | $22.1M | $33.3M | |
Change in Accounts Receivable | $318K | $138K | $2M | $1.9M | $748K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.9M | -$8.3M | -$13.8M | -$20.5M | -$33M | |
Capital Expenditures | $2.2M | $3.3M | $2.3M | $4.9M | $3.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.2M | -$304.1M | $21.3M | $43.5M | -$230.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $16K | -$18K | $873K | $516K | |
Cash From Financing | $5.4M | $148K | $34K | $1.4M | $368.7M | |
Beginning Cash (CF) | $36.1M | $399M | $46.4M | $38.1M | $56.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | $4K | -$13K | |
Additions / Reductions | -$689K | -$312.3M | $7.5M | $24.4M | $105.5M | |
Ending Cash (CF) | $35.4M | $86.8M | $53.9M | $62.5M | $162.4M | |
Levered Free Cash Flow | -$6.1M | -$11.6M | -$16.2M | -$25.4M | -$36.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.